Trials / Completed
CompletedNCT07113366
Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis
Improvement of Atopic Dermatitis Symptoms and Signs by Jelly Fig (Ficus Awkeotsang Makino) Extract
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Kaohsiung Veterans General Hospital. · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to evaluate the efficacy and safety of a topical formulation containing Ficus awkeotsang Makino extract (FAE), derived from jelly fig, in participants with mild to moderate atopic dermatitis. Ficus awkeotsang is a traditional plant native to Taiwan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FAE cream | Ficus awkeotsang Makino extract (FAE) |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-06-01
- Completion
- 2024-11-30
- First posted
- 2025-08-08
- Last updated
- 2025-08-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07113366. Inclusion in this directory is not an endorsement.